Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ethema HealthGRST EBITDA Margin % is 0.33% as of Dec. 2025, which is 96% below its 10-year median of 8.54. The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Ethema Health ranks worse than 55.27% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ethema Health's EBITDA for the
three
months ended in Dec. 2025 was $0.02 Mil. Ethema Health's Revenue for the
three
months ended in Dec. 2025 was $4.81 Mil. Therefore, Ethema Health's EBITDA margin for the quarter that ended in Dec. 2025 was 0.33%.
Ethema Health (OTCPK:GRST) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ethema Health EBITDA Margin % Related Terms
Ethema Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ethema Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRST vs FCHS, PAIYY, FOXOD: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ethema Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ethema Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ethema Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ethema Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ethema Health (GRST) has a EBITDA Margin % of 0.33% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ethema Health and its competitors. This is 96% below median its historical median of 8.54. According to the industry distribution chart, Ethema Health ranks #367 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 55.3%.
Is Ethema Health's EBITDA Margin % too high?
Ethema Health's current EBITDA Margin % of 0.33% is 96% below median its 10-year median of 8.54. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ethema Health's value of 0.33% is 96.8% below this industry median. Based on the distribution chart, Ethema Health ranks #367 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Ethema Health's EBITDA Margin % compare to FCHS and PAIYY?
According to the Healthcare Providers & Services industry distribution chart, Ethema Health ranks #367 out of 664 companies for EBITDA Margin %. This places Ethema Health in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Ethema Health's value of 0.33% is 96.8% below this benchmark. While the company's 10-year median is 8.54 vs. the industry median of 10.21, Ethema Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ethema Health's current EBITDA Margin % of 0.33% is 96.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ethema Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ethema Health's current EBITDA Margin % is 0.33%, which is 96% below median its own 10-year median of 8.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ethema Health stock overvalued right now?
Ethema Health (GRST) has a current EBITDA Margin % of 0.33%. The current EBITDA Margin % is 0.33%, which is 96% below median its 10-year median of 8.54 and 96.8% below the Healthcare Providers & Services industry median of 10.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ethema Health (GRST), the current EBITDA Margin % is 0.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ethema Health Corp is engaged in developing and operating medical clinics in Delray Beach Florida. It provides addiction and mental health treatment facilities. The company's operating segment includes Rehabilitation Services provided to customers. It generates maximum revenue from the In-Patient services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRST has been successfully added to your 
